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ABSTRACT
Hypoxia-inducible factors (HIF)-1a and HIF2a are
major transcription factors required for adaptive
responses to hypoxia. HIFs form a complex with
aryl hydrocarbon receptor nuclear translocator
(ARNT) to bind to the regulatory regions of target
genes. The acetylation of histones by histone
acetyltransferases (HATs) is one of the epigenetic
marks associated with active chromatin. Indeed,
HIFs recruit p300 HAT to hypoxia response
elements (HREs) within gene regulatory regions.
Here, we report an unusual HIF-mediated transcrip-
tional activation in ovarian clear cell carcinoma
(CCC). While characterizing coagulation factor VII
(FVII) gene induction during hypoxic conditions, we
observed that the interaction of HIF2a with Sp1, but
not with ARNT, could induce transcription of FVII in
a HRE-independent manner. Unexpectedly, this
gene activation is associated with histone deacety-
lation. We found that a class II HDAC, HDAC4, is
recruited with HIF2a to the FVII promoter as a
co-activator, while p300 HAT negatively regulated
this process. Furthermore, this mechanism can
be synergistically enhanced via a deacetylation-
dependent pathway when cells are simultaneously
exposed to hypoxic and serum-free conditions.
These results suggest the presence of a stress-
responsive transcription mediated by the HIF2a/
Sp1/HDAC4 network and explain how CCC shed
their procoagulant activity under hypoxia.
INTRODUCTION
The activation of various signaling pathways allows cells
to adapt to be environmental stresses, such as O2 and/or
nutrient deprivation. Hypoxia inducible factors, HIF1a
and HIF2a, are two of the main nuclear transcription
factors that permit the appropriate cellular responses to
reduced oxygen tension surrounding cancerous tissues (1).
Under normal oxygen levels, or normoxia, HIF expression
levels are very low because these factors undergo
proteasomal degradation. However, under O2-deprived
conditions, HIFs escape from ubiquitination by E3 ubi-
quitin ligases and accumulate within the cell. HIFs form
heterodimeric complexes with the constitutively expressed
aryl hydrocarbon receptor nuclear translocator (ARNT,
also called as HIF1b), enabling them to bind to hypoxia
response element (HRE) sequences (1). This HIF–ARNT
complex is associated with gene regulatory regions and
functions to enhance transcription.
Histone acetylation is closely associated with transcrip-
tional activation. Histone acetyltransferases (HATs) are
recruited to regulatory regions of genes to catalyze the
acetylation of histones and make chromatin structures
more accessible for other transcriptional activators (2).
Histone deacetylation, in contrast, is catalyzed by
histone deacetylases (HDACs), which are associated
with chromatin when transcription is down-regulated
(2). One of the most important HATs, p300, is responsible
for constitutive and inducible activation of numerous
genes (2). Indeed, p300 is a transcriptional co-activator
for HIFs, responsible for activating crucial events during
cell survival, such as angiogenesis and metastasis (3).
Blood coagulation factor VII (fVII) is a key enzyme
in the extrinsic coagulation cascade (4). Predominantly
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receptor, tissue factor (TF) and, when bound to TF, is
converted to its active form (fVIIa), thereby triggering a
downstream coagulation cascade (5). This TF–fVIIa
complex is known to initiate key pathogenic mechanisms
in cancer, including cell motility, invasion, cell survival
and angiogenesis (5), and is a major cause of thrombosis
in cancer patients. In particular, in ovarian clear cell car-
cinoma (CCC), one of the most aggressive ovarian
malignancies, the TF–fVIIa complex can cause venous
thromboembolism (6), a common complication of cancer.
In CCC, fVII synthesis is induced in response to
hypoxia (6,7), leading to the secretion of microvesicles
that contain the TF–fVIIa complex; this secretion is
likely to be one of the key causes of thrombosis in CCC-
type patients with poor prognosis (6). We previously
showed that various cancer cells could ectopically synthe-
size fVII (7). When this TF–fVIIa complex is derived from
ectopically expressed fVII, cancer cells show enhanced
motility and invasion (7). However, detailed mechanisms
of the fVII induction are not clear. While we were
characterizing the mechanism of hypoxic fVII-gene acti-
vation, we unexpectedly observed that HIF2a, but not
HIF1a, binds to the FVII promoter region in the
absence of HRE sequences (7), implicating that a novel
cellular mechanism of adaptive response may exist. Thus,
in this study, we sought to determine the detailed mech-
anisms of this unusual gene activation, including the in-
volvement of histone acetylation, in an attempt to gain an
understanding of the molecular mechanism of thrombosis
in CCC patients. In addition, because cancer tissues with
poor vascularization tend to be deﬁcient in other serum
factors in addition to molecular oxygen and nutrients (8),
we further investigated how the deﬁciency of these factors
affects this transcriptional regulation.
MATERIALS AND METHODS
Cell culture and reagents
Human cancer cell lines were maintained as previ-
ously described (7). Acriﬂavine (A8126) and tunicamycin
(T7765) were purchased from Sigma (St Louis, MO,
USA). Cell culture media used for experiments under
glucose-free condition were from Invitrogen (11875 and
11879; Carlsbad, CA, USA).
Expression vectors
Expression vectors of HIF1a, HIF2a, and p300 were
prepared by PCR ampliﬁcation using PrimeScript 1st
strand cDNA synthesis kit (Takara, Shiga, Japan) with
the following primers: HIF1a,5 0-CTAGCTAGCACCG
ATTCACCATGGAGGGCG-30 (forward; F) and 50-GG
GGTACCGCTCAGTTAACTTGATCCAA-30 (reverse;
R); HIF2a,5 0-TCGACGCGTCGACAATGACAGCTG
ACAAGGAG-30 (F) and 50-GCTCTAGAGCTCAGGT
GGCCTGGTCCAG-30 (R); p300, 50-CCGCTCGAGCC
TCGCTTGTATCTCCGAAAGAAT-30 (F) and 50-GGG
GTACCGGTGTCTCTAGTGTATGTCTAGTGTACT
CTGT-30 (R). Fragments containing full-length cDNA
derived from OVSAYO cells were inserted into the pCI
vector (Promega, Madison, WI, USA) at the Nhe I/Kpn
I (HIF1a), Mlu I/Xba I (HIF2a), and Xho I/Kpn I (p300)
sites.
Small interference RNA experiments
Small interference RNAs (siRNAs) for HIFs were
prepared as previously described (9). siRNAs for Sp1,
p300, ARNT, and HDAC4were ON-TARGET plus
SMART pool reagents (Dharmacon, Lafayette, CA).
Silencer Negative Control 1 RNAi (Ambion) was used
as non-speciﬁc siRNA. Transfection was performed
using lipofectamine RNAi MAX (Invitrogen).
Quantitative RT-PCR analysis
We determined mRNA levels by quantitative RT-PCR, as
previously described (7).
Construction of luciferase plasmids and reporter
gene assay
A luciferase plasmid construct with the FVII 50 full pro-
moter region was prepared as previously described (10).
Mutant constructs were prepared using the QuikChange
mutagenesis Kit (Stratagene, La Jolla, CA). Luciferase
assays were performed as previously described (10).
Western blot analysis
Western blotting was performed as previously described
(10). Antibodies used for western blotting or immunopre-
cipitation were Flag M2 (F1804, Sigma), HA (H6908,
Sigma), HDAC1 (sc-7872, Santa Cruz Biotechnology,
Santa Cruz, CA), HDAC2 (Sc-7899, Santa Cruz),
HDAC3 (Sc-11417, Santa Cruz), HDAC4 (ab1437,
Abcam, Cambridge or 2072S, Cell Signaling, Danvers,
MA), SIRT1 (1104-1, EPITOMICS, Burlingame, CA),
ARNT (NB100-110, Novus Biologicals, Littleton, CO),
Sp1 (NB600-232, Novus Biologicals), and CHOP (2895,
Cell Signaling).
Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) analysis was
performed as previously described (10). The primers,
probes and antibodies used are described elsewhere (7).
Other antibodies used in this study were as follows:
ARNT (NB100-110, Novus Biologicals), acetyl-histone
H3 (06-599, Millipore, Temecula, CA), acetyl-histone H4
(06-866, Millipore), histone H3 (ab1791, Abcam),
HDAC4 (ab1437, Abcam), HDAC-1 (sc-7872, Santa
Cruz) and HDAC-2 (Sc-7899, Santa Cruz). Primers used
for ChIP analysis of VEGF-HRE region by real-time PCR
were 50-GCCTCTGTCTGCCCAGCTGC-30 and 50-GTG
GAGCTGAGAACGGGAAGC-30; hybridization probes
were 50-TTGCCAGACTCCACAGTGCATACGTGG
-FITC-30, and 50-LCRed640-TCCAACAGGTCCTCTTC
CCTCCCAG-30.
Co-immunoprecipitation analysis
Expression vector of Sp1 tagged with a ﬂag peptide at
the N-terminus (pCI–Sp1–Flag) and an expression
vector of HIF2a tagged with a hemagglutinin peptide
5390 Nucleic Acids Research, 2012,Vol.40, No. 12(pCI–HIF2a–HA) were prepared using QuikChange
kit by inserting corresponding DNA sequences into the
pCI–Sp1 and pCI–HIF2a plasmids, respectively. Expre-
ssion vectors of truncated HIF2a were also prepared
using QuikChange kit as deletion mutants of
pCI–HIF2a–HA. pCI–Sp1 was prepared by inserting the
full-length cDNA fragment ampliﬁed from OVSAYO cells
at the XhoI/KpnI cloning site. Primers used were 50-CCGC
TCGAGGACAGGACCCCCTTGAGCTTG-30 (F) and
50-GGGGTACCGGGGTATGGCCCATATGTC
TCTG-30 (R). After transfection (24h), cells were
lysed with RIPA buffer (Sigma, R0278) and incubated
with normal IgG, anti-Flag, or anti-HA antibodies
(see ‘‘Western blot analysis’’ section) at 4 C for 2h.
Antibody-protein complexes were captured using
Dynabeads-protein G (Invitrogen). Immunoprecipitates
were analyzed by western blotting. Immunoprecipitation
of endogenous Sp1 was performed using an anti-Sp1
antibody (NB600-232, Novus Biologicals) as described
above.
RESULTS
HIFs mediate FVII-gene activation under hypoxia
We previously reported that the FVII gene is inducible in
cancer cells under hypoxia-mimetic conditions created
with CoCl2 treatment (7), with highest FVII induction
observed in the ovarian CCC cells, OVSAYO and
OVISE. Thus, we used these cell lines to further examine
the mechanism of the hypoxic gene activation. Using
OVSAYO cells, we ﬁrst performed a transcription
factor-binding site analysis by inspecting an approximate
2500bp region spanning an authentic FVII promoter
and intron 1 (positions 3781–6180, GenBank accession
number NG_009262; http://www.gene-regulation.com
and http//:www.cbrc.jp/research/db/TFSEARCHJ.html).
Our results identiﬁed the existence of candidate HREs
upstream of the FVII 50 region (positions 4104–4109 and
4281–4286, accession number NG_009262) close to pre-
dicted Alu elements (positions 4121–4417, accession
number NG_009262 and Figure 1A). However, ChIP
analysis showed that HIFs did not bind to this region
(Figure 1A and B, bar a) in response to CoCl2 treatment
(7) although both HIFs could occupy a HRE region of
VEGF gene (Figure 1B). Unexpectedly, we found that
HIF2a principally bound to the FVII promoter region
(Figure 1A, bar b) in the absence of a HRE site in
OVSAYO cells (7), and to the FVII promoter under real
hypoxic (1% O2) culture conditions (Figure 1B); this
suggests that HIF2a may be responsible for FVII gene
induction. Finally, using western blotting and ChIP
analysis, we conﬁrmed the preferential binding of HIF2a
to the FVII promoter region in an additional CCC cell
line, OVISE (Supplementary Figure S1A and S1B).
We next tested the effect of HIFs on FVII activation
under CoCl2 or 1% O2 conditions. Using OVSAYO cells,
we ﬁrst suppressed HIF induction using HIF-speciﬁc
RNA interference (RNAi) (9) and then examined its
effect on fVII transcriptional induction using real-time
RT-PCR analysis. We observed that fVII induction was
suppressed by the knock-down of not only HIF2a but also
HIF1a (Figure 1C), as compared to non-speciﬁc (NS)
siRNA-transfected experiments, and this could be
further ampliﬁed by the concurrent knock-down of both
HIFs (Figure 1C). In addition, quantitative ChIP analysis
by real-time PCR supported our earlier ﬁndings that
HIF1a does not bind to the FVII promoter under
hypoxia (Supplementary Figure S2A); this eliminated the
possibility that trace amounts of HIF1a up-regulated
FVII transcription through association with the
promoter region.
To investigate whether the FVII promoter region is
activated by HIFs, we next performed a reporter gene
analysis. A FVII fragment ( 400/+1), which covers the
full FVII promoter activity (10), was fused to a luciferase
vector (Supplementary Figure S2B). The reporter assay
revealed that the promoter was activated by ectopic
expression of HIF2a, whereas transfection of the same
concentration (400ng) of HIF1a induced a very weak ac-
tivation (Figure 1D). Interestingly, the promoter was most
activated by the simultaneous expression of equal concen-
trations of both HIFs (200ng each; Figure 1D). Positive
control experiments with a HRE sequence of the VEGF
gene (Supplementary Figure S2B) showed enhanced
luciferase activity with HIF induction (Supplementary
Figure S2C). As previously reported, HIF2a caused the
most activity, likely due to the differential regulation of
HIF function and expression (11,12). Unlike with FVII
activation, the activation of VEGF did not increase upon
co-transfection of both HIFs. Together, these results
suggest that HIFs may co-operatively activate the FVII
promoter.
An Sp1-binding site is responsible for activation of FVII
To further deﬁne the regions responsible for FVII activa-
tion, mutant luciferase constructs were co-transfected with
both HIFs into OVSAYO cells. Constructs lacking a
known Sp1-binding site demonstrated a weak response
to the HIFs, similar to the response observed with the
empty vector (Figure 2A). Using additional deletion con-
structs (Figure 2B), we found that promoter activation by
HIFs was particularly impaired when the core Sp1-
binding site of the FVII gene was mutated: the 50-TCCT
CCCCTCCCC-30 sequence (13) (Figure 2B; construct 4).
Constructs with single or triple copies of this sequence
responded primarily to HIF2a, and when co-expressed
with HIF2a, HIF1a co-operatively activated the luciferase
expression (Figure 2C). Together, these ﬁndings suggest
that the Sp1 site is responsible for FVII induction by
HIFs.
HIF2a–Sp1 interaction induces FVII activation under
hypoxia
We previously showed that Sp1 binds to the
FVII promoter in OVSAYO cells (10). Thus, we next
tested whether Sp1 is required for FVII induction under
hypoxia-mimetic and real-hypoxic conditions. In
OVSAYO cells, RNAi was ﬁrst used to suppress Sp1
without affecting HIF protein levels (Figure 3A), before
the cells were cultured with CoCl2. Real-time PCR
Nucleic Acids Research, 2012,Vol.40, No. 12 5391analysis revealed that Sp1 knockdown markedly reduced
fVII mRNA induction in both OVSAYO (Figure 3B) and
OVISE cells (Supplementary Figure S2D), and this same
Sp1 dependency was observed under real-hypoxic condi-
tions (Supplementary Figure S3A). Induction of the
VEGF gene was not signiﬁcantly inﬂuenced by a
decrease in Sp1 (Figure 3B), even though Sp1 binds to
the VEGF promoter, and is essential for basal promoter
activity (14). Following this, we tested whether HIF2a
binding to the FVII promoter is diminished in Sp1-
siRNA-treated OVSAYO cells under CoCl2 treatment.
Using ChIP analysis, we observed a decrease in the
binding of HIF2a by Sp1-knockdown, although the
binding of both HIFs to the VEGF-HRE region was not
signiﬁcantly altered (Figure 3C).
We next wanted to examine whether HIF2a interacts
with Sp1. Immunoprecipitation analysis revealed that
HIF2a induced in OVSAYO cells cultured under 1%
O2 for 16h can be precipitated with endogenous Sp1
(Figure 4A); this suggests that Sp1 and HIF2a interact
to form a protein complex. Furthermore, HA-tagged
HIF2 and Flag-tagged Sp1 were co-transfected into
OVSAYO cells (Figure 4B), and immunoprecipitated
with anti-HA or anti-Flag antibodies. Western blotting
results showed that HIF2a–HA formed a protein
complex with Sp1–Flag in OVSAYO cells (Figure 4C).
To determine the binding sites, we then co-transfected
various deleted mutants of HIF2a (Figure 4D) with
Sp1–Flag. We observed that Sp1 binds to HIF2a, even
in the absence of the HLH (90–870) and PAS-A
(161–870) domains (Figure 4D and E), and interacts
with the C-terminal region that includes the CTAD
domain (551–870) of HIF2a, but not when this portion
was fused with the middle region containing the NTAD
domain. Sp1 also associated with the HLH-PAS-A
portion of the protein (1–201) as well as both PAS
domains (90–351), but not with the HLH domain alone.
To verify the Sp1-dependent binding, we next per-
formed ChIP analysis with an anti-HIF2a antibody on
OVSAYO cells transfected with luciferase constructs and
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Figure 1. HIFs mediate FVII activation under hypoxia. (A) Schematic representation of FVII 50-region. Black bars indicate the PCR amplicon for
ChIP assay. Nucleotide sequence with capital letters represents the HRE sequence predicted by a computer search. Gray bar designates the position
of predicted putative Alu repetitive elements. Gray and black circles indicate Sp1 and HNF-4 binding sites, respectively. A bent arrow and an asterisk
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respectively. Data were also estimated by real-time PCR. Fold enrichment of immunoprecipitated DNA for each transcription factor against
background (templates due to non-speciﬁc binding with IgG) is shown. Data are mean of three independent experiments (hereafter n=3)±SD.
(C) Effect of HIFs on the expression of FVII in OVSAYO cells. Cells were cultured in 500mM CoCl2 for 4h and 1% O2 for 16h and analyzed with
real-time RT-PCR. NS: non-speciﬁc. Data are the mean (n=3)±SD. (D) Luciferase reporter analysis of FVII activation by HIFs. A FVII-promoter
construct (Supplementary Figure S2B) was transfected into OVSAYO cells with each HIF separately (400ng) or together (200ng of each). Inset:
western blotting analysis of HIFs expressions 24h post-transfection. b-actin shows equal protein loading. Relative promoter activities are shown as
percentages of the activity from cells transfected with both empty vectors. Variations in transfection efﬁciency were corrected with a control Renilla
luciferase vector. Data are the mean (n=3)±SD.
5392 Nucleic Acids Research, 2012,Vol.40, No. 12treated with CoCl2 (Supplementary Figure S3B). PCR
analyses revealed that HIF2a binds to the full-length
promoter, and that binding can be abrogated upon
deletion of the Sp1 site. In addition, CoCl2 treatment
did not affect the expression (6) or binding
levels (Supplementary Figure S3C) of Sp1 to the FVII
promoter, suggesting that HIF2a interacts with Sp1 that
is constitutively associated with promoter region, and that
HIF2a does not activate the FVII promoter by increasing
Sp1 binding.
FVII activation does not require ARNT
HIFs induced under hypoxia form heterodimeric
complexes with constitutively expressed ARNT to bind
HRE sequences. Thus, we next sought to determine
whether this complex formation is necessary for FVII ac-
tivation. ChIP analysis revealed that ARNT did not bind
to the FVII promoter in response to CoCl2 stimulation
(Figure 5A); however, ARNT was recruited to the
VEGF-HRE site under these conditions (Figure 5A).
Following this, we assessed the effect of ARNT expression
on FVII and VEGF gene inductions. Using RNAi, we ﬁrst
suppressed ARNT in OVSAYO cells (Figure 5B), in which
induction of HIFs was not affected (Figure 5B). Using
real-time RT-PCR analysis, we detected a decrease and
an increase in fVII and VEGF mRNA levels, respectively,
when ARNT-suppressed cells were cultured under
normoxia (Figure 5C). However, there was a marked re-
duction in VEGF mRNA when OVSAYO cells were
treated with CoCl2 or 1% O2 with no change in the
percentage of fVII mRNA as compared with the
negative control (Figure 5C). Finally, we tested whether
inhibiting the formation of the HIF-ARNT complex
inﬂuences FVII activation. OVSAYO cells were cultured
with CoCl2 for 4h in the presence of a heterodimerization
inhibitor, acriﬂavine (ACF) (15). Real-time RT-PCR
analysis showed that ACF treatment increased the
fVII mRNA level via unknown mechanism (Supple-
mentary Figure S4A), and reduced the mRNA levels of
the HRE-dependent VEGF and ENO1, as expected
(Supplementary Figure S4A).
Hypoxic FVII activation associates with deacetylation
HIFs recruit p300 HAT to HREs and activate target
genes. Therefore, we wanted to assess how histone acetyl-
ation is linked to FVII activation. First, we tested the
effect of CoCl2 treatment on the acetylation of histones
H3 and H4 within the FVII promoter region in OVSAYO
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Nucleic Acids Research, 2012,Vol.40, No. 12 5393cells. As expected, ChIP analysis of VEGF-HRE
region showed an elevation in the histone acetylation
levels (Figure 6A, left and Supplementary Figure S4B).
However, we unexpectedly found that histones within
the FVII promoter were deacetylated in response to
CoCl2 treatment (Figure 6A, middle and Supplementary
Figure S4B). ChIP analysis also showed that the associ-
ation level of histone H3 within the FVII promoter was
unchanged following CoCl2 stimuli (Figure 6A, right),
further verifying that decreased acetylation levels did not
result from histone eviction. We also conﬁrmed that
histones were deacetylated within the FVII promoter
under CoCl2 treatment in OVISE cells (Supplementary
Figure S4C), and under real hypoxic conditions in
OVSAYO cells (Figure 6A, middle).
Steady-state histone acetylation across chromatins is
maintained by the dynamic equilibrium between HATs
and HDACs (2,16). Although we observed p300 binding
to the FVII promoter in OVSAYO cells, the association
level was not altered after CoCl2 treatment (Figure 6B).
Conversely, as expected, p300 binding to VEGF-HRE was
elevated by CoCl2 treatment (Figure 6B). Since hypoxic
FVII activation is associated with histone deacetylation,
we tested the role of p300 on this transcriptional activa-
tion. Using RNAi, p300 was ﬁrst suppressed (Figure 6C),
before the cells were cultured under 1% O2 for 16h. Using
real-time RT-PCR, we observed an increase in the fVII
transcript level with p300-knockdown, whereas VEGF
transcript levels were diminished (Figure 6D). Further-
more, ectopic expression of p300 suppressed FVII
promoter activation when HIF2a alone or both HIFs
were expressed (Figure 6E). In contrast, there was a rela-
tively low increase in VEGF-HRE activation by HIF1
with ectopic p300 expression, similar to the level
observed by HIF2 expression (Figure 6E). These results
demonstrate that deacetylation promotes FVII activation
by HIFs.
HDAC4 is a co-activator of FVII induction
As HRE-dependent mechanisms recruit HAT to activate
transcription, we surmised that HDACs may co-activate
FVII under hypoxic conditions. Thus, we ﬁrst examined
recruitment of the ubiquitously expressed HDAC1 and
HDAC2 to the FVII promoter region in response to
CoCl2 treatment. ChIP analysis revealed no change in
the association levels of HDAC1 and HDAC2 after
CoCl2 exposure (Supplementary Figure S5A). A recent
report found that SIRT1 deacetylated HIF2a (12); there-
fore, we tested whether class III HDAC(s) contributed to
FVII induction. Whilst ChIP analysis revealed a weak
increase in SIRT1 levels (Supplementary Figure S5B)
and some binding to the FVII promoter in OVSAYO
cells, this was not enhanced by CoCl2 stimulation
(Supplementary Figure S5C). In addition, although
SIRT1 associated with HRE of the VEGF gene, the
binding was abrogated with CoCl2 (Supplementary
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regions. Data were estimated by qPCR. Data are the mean (n=3)±SD.
5394 Nucleic Acids Research, 2012,Vol.40, No. 12Figure S5C). Similarly, the class III HDAC activator,
resveratrol (12), did not promote FVII activation under
CoCl2 treatment (Supplementary Figure S5D).
We next examined whether class II HDAC(s) (17) affect
FVII activation. Western blotting showed that the class II
HDAC, HDAC4 (Figure 7B) rather than HDAC5
(Supplementary Figure S5E), was predominantly
expressed in OVSAYO cells. ChIP analysis showed the
recruitment of HDAC4 to the FVII promoter in
response to CoCl2 treatment or hypoxia (Figure 7A).
Real-time RT-PCR analysis revealed that HDAC4-
knockdown does not affect basal fVII transcript levels
in OVSAYO cells (Figure 7C); however, we observed a
signiﬁcant reduction in its induction with CoCl2 treatment
(Figure 7D) without inﬂuencing HIF expression
levels (Figure 7B) or HIF2a binding to FVII promoter
(Figure 7E). In addition, immunoprecipitation analysis
revealed an association between HDAC4 and endogenous
Sp1–HIF2a complex under hypoxia (Supplementary
Figure S5F).
We also tested whether HDAC3 binds to the FVII
promoter in response to CoCl2 treatment. Recently, it
was shown that HDAC4 recruits and activates the tran-
scription factor, FOXO, via deacetylation by HDAC3
(18). Although HDAC3 is expressed in OVSAYO cells
(Supplementary Figure S5B), we only observed weak
binding of HDAC3 to the FVII promoter region, which
was not enhanced with CoCl2 treatment (Supplementary
Figure S5G). In comparison, HDAC3 showed a strong
interaction with HRE of the VEGF gene in OVSAYO
cells (Supplementary Figure S5G).
Serum deprivation but not glucose deprivation
synergistically enhances FVII activation under hypoxia
Cancercellsmustadapttoenvironmental stressconditions,
particularly in cases where inefﬁcient vascularization
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Nucleic Acids Research, 2012,Vol.40, No. 12 5395within the tissue leads to O2 and nutrient deprivation (8).
Thus, we ﬁrst tested how glucose deprivation inﬂuences
FVII-gene activation under hypoxia. Real-time RT-PCR
analysis revealed that although glucose deprivation
weakly increased fVII mRNA levels, the transcript levels
were not further enhanced when cells were simultaneously
exposed to 1% O2 (Supplementary Figure S6A). These
results are consistent with data showing decreased HIF
expression in cancer cells under glucose-free conditions
(19) and the weak expression of HIF observed in
OVSAYOcellsunderglucose-deprived conditions(Supple-
mentary Figure S7B).
Serum starvation has been reported to induce a cellular
response to hypoxia through the hypoxia-inducible
factor-independent pathway (20). Hypoxia and serum
deprivation are known to be components of ischemia
(21,22), and we have previously demonstrated that CCC
cells efﬁciently shed TF-fVIIa-containing microvesicles
under both hypoxic and serum-free conditions (6). Since
hypoxic cancer tissues should also be devoid of serum
factors other than O2 and nutrients, we next examined
whether serum starvation affects FVII activation. Cells
were cultured with or without fetal calf serum (hereafter
serum) under normoxia or 1% O2. Real-time RT-PCR
analysis revealed a slight increase in fVII transcript
levels in serum-deprived cells cultured under normoxia
(Figure 8A); this is possibly owing to a weak induction
of HIFs (Supplementary Figure S6B). However, fVII was
synergistically increased at both the mRNA and protein
levels when cells were exposed to both hypoxic and
serum-free conditions (Figure 8A and B). In contrast,
the VEGF mRNA levels were not signiﬁcantly inﬂuenced
(Figure 8A). ChIP analysis showed that HIF2a predom-
inantly binds to the FVII promoter (Figure 8C), similar to
that observed in serum-plus conditions (Figure 1B); this
eliminated the possibility that an altered binding pattern
of HIFs caused this synergistic activation. Furthermore,
the association of Egr-1 with the FVII promoter
under normoxia expression was unchanged by
exposing the cells to hypoxic and serum-free conditions
(Supplementary Figure S6C); Egr-1 is a transcription
factor responsible for hypoxic activation of tissue factor
gene by substituting Sp1 binding (23). Knockdown of
p300 and HDAC4 increased and decreased hypoxic fVII
mRNA induction, respectively, under serum-free condi-
tions (Figure 8D). Furthermore, the acetylation level of
histones within the FVII promoter was diminished under
both hypoxic and serum-free conditions (Figure 8E), as in
the case of CoCl2 treatment, demonstrating a synergistic
activation associated with deacetylation.
UPR signaling is not responsible for the synergistic
transcriptional activation
Other than mechanisms mediated by HIFs, endoplasmic
reticulum (ER) stress is a common cellular stress induced
by stimuli, such as O2 and nutrient deprivation (24,25).
Cells are able to adapt to such environments via
unfolded protein response (UPR), which is mediated
by the induction of various stress response proteins,
such as CHOP, and can co-operate with HIF signaling.
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5396 Nucleic Acids Research, 2012,Vol.40, No. 12We hypothesized that UPR contributes to the synergistic
FVII activation. We ﬁrst examined whether cells cultured
under our experimental conditions undergo ER stress.
Western blotting showed that ER stress via CHOP induc-
tion only occurred when OVSAYO cells were exposed to
both hypoxic and serum-free conditions (Figure 8F).
We next tested whether UPR causes synergistic FVII in-
duction. OVSAYO cells were cultured in the presence of
an ER stress-inducing agent, tunicamycin (Tun) (26), in
the presence of serum. The results conﬁrmed that CHOP is
induced by Tun treatment (Figure 8G). We next examined
the effect of Tun on FVII expression under hypoxia.
Real-time RT-PCR analysis revealed that, although Tun
treatment elevated FVII transcript level under normoxia,
it was not further up-regulated by hypoxia (Figure 8H).
In addition, HIF levels induced under 1% O2 were largely
unchanged by simultaneous Tun exposure (Figure 8I);
these results suggest that UPR is not involved in the syn-
ergistic activation. This result is consistent with data
showing that glucose deprivation under normoxia
weakly enhanced FVII activation (Supplementary Figure
S6A) with induction of CHOP (Supplementary Figure
S7A), as UPR is known to be induced in cancer cells
cultured under glucose-free condition (26).
DISCUSSION
Hypoxic activation of the HRE-dependent CAIX (27),
RORA (28), and G3PDH (29) by HIF1a is modulated
by Sp1 binding near the HRE. In addition, HIFs have
been shown to interfere with the formation of the
c-Myc/Sp1 and c-Myc/Max complexes that regulate gene
expressions necessary for cell cycle (30) and mismatch
repair (31) controls. Thus, Sp1 is generally considered to
be an important regulator of gene expression under
hypoxic conditions. Here, we showed a novel transcrip-
tional activation of FVII mediated by HIFs that involves
(i) the interaction of HIF2a with Sp1, but not with
ARNT; (ii) an association with histone deacetylation;
and (iii) a synergistic activation under serum-free condi-
tions. Furthermore, it is plausible that genes potentially
regulated by this mechanism may be important in the
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Nucleic Acids Research, 2012,Vol.40, No. 12 5397cellular response to severe hypoxic conditions with a poor
supply of serum factor(s). Together, these ﬁndings have
provided us with some explanation as to why CCC cells
cultured under hypoxia/serum starvation can efﬁciently
shed microvesicles enriched with fVIIa activity.
HIFs bind with ARNT through PAS domains at their
N-terminus (32), whereas the C-terminus interacts with
other transcriptional regulators, such as p300 and SIRT1
(33). In this study, we found that both ends of HIF2a can
associate with Sp1; however, further studies are required
to clarify the mechanisms of the interaction between Sp1
and the C-terminus of HIF2a. It was reported that
cysteine (C)/histidine (H)-rich zinc ﬁnger domain of a
Sp1/KLF family protein can bind to p300/CBP (34).
Given that CTAD domain of HIF1a can associate with
a C/H-rich zinc-binding motif (CH1) of p300/CBP (35), it
seems likely that zinc-ﬁnger domain of Sp1 binds to the
C-terminus of HIF2a through interaction with CTAD.
However, the binding at the C-terminal region is
abrogated by the presence of the middle region that
contains the NTAD domain; this suggests that HIF2a
has an inhibitory domain that affects the interaction
between the C-terminal region of HIF2a and Sp1. It
would be interesting to ascertain whether this inhibitory
effect participates in the physiological regulation of
HIF2a function. In addition, we also observed that the
HLH region alone does not associate with Sp1. From
these ﬁndings, we suggest that full-length HIF2a binds
to Sp1 through its PAS domains. This is similar to a
previous report showing that PAS domains of ARNT
can associate with zinc-ﬁnger domain of Sp1 (36).
Assuming that HIF2a binds with ARNT through its
PAS domains, our data may explain why ARNT is not
recruited with HIF2a to the FVII promoter under
hypoxia.
Notably, the mechanism described in this study is
similar to that of constitutive FVII expression under
normoxia in breast cancer cells (10), where the same
Sp1-binding site is critical for activation, and HIFs
co-operatively activate transcription. We suggest that
HIF1a may indirectly activate the FVII promoter
region, as HIF1a does not directly bind to the FVII
promoter, yet demonstrates co-operative effects when sim-
ultaneously expressed with HIF2a. The present mechan-
ism is distinct from that of ABCC8-gene activation under
hypoxia, in which there is a HIF1a-mediated up-
regulation of Sp1 (37). This is interesting, as we showed
that the expression and binding levels of Sp1 to the FVII
promoter under normoxia in OVSAYO cells were not
inﬂuenced by CoCl2 and hypoxia treatments.
Our ﬁnding that FVII activation associates with
deacetylation was unexpected, because under normal cir-
cumstances, transcriptional activation closely associates
with hyperacetylation of histones, not deacetylation.
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5398 Nucleic Acids Research, 2012,Vol.40, No. 12Indeed, previous work shows that basal FVII transcription
is dependent on histone acetylation, with enhanced fVII
mRNA levels in response to treatment of cancer cells
with the HDAC inhibitor, trichostatin (10). Our data,
showing that the expressions of p300 and HDAC4
correlate with a decrease and an increase in fVII
transcript levels, respectively, suggests that the association
between histone deacetylation and HIF2a recruitment
may be a critical step for the formation of active
chromatin.
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Nucleic Acids Research, 2012,Vol.40, No. 12 5399Although this study has focused on the acetylation
status of histones, it is also possible that deacetylation of
HIF2a by HDAC4 may affect its function in the regula-
tion of FVII transcription in CCC cells, since acetylation
of lysine residues is critical to the functional regulation of
HIF (33). However, it was recently reported in cancer cells
that HDAC4 causes deacetylation of HIF1a, but not
HIF2a, to enhance its stability (38). Since HIF1a partici-
pates in FVII activation in CCC cells, HDAC4 may affect
FVII induction via modulation of HIF1a. Furthermore,
HDAC4 was recently shown to deacetylate the transcrip-
tion factor, FOXO, in liver cells to enhance its binding
activity to target genes required for gluconeogenesis
(18,39). However, it is unlikely that HDAC4 recruitment
contributes to the interaction between HIF2a and Sp1 in
the FVII promoter region, as we showed that HIF2a
binding is not inﬂuenced by HDAC4 knockdown. It is
also improbable that the synergistic activation of FVII is
due to enhanced HIF2a binding, as the ChIP assay
revealed that HIF2a binding under hypoxia is not
enhanced by serum deprivation.
The tumor microenvironment is generally associated
with hypoxia and poor nutrient supply due to inefﬁcient
vascularization (26). To inhibit apoptosis, cancer cells
respond and adapt to these pressures by activating
cellular mechanisms, such as angiogenesis, cell invasion,
and signaling. Although the adaptive responses by HIFs
are one of the major pathways induced under hypoxia, the
co-operation of additional mechanisms and signaling by
UPR assist cancer cell adaptation to hypoxia and nutrient
deﬁciency, thereby promoting cell survival. In this study,
we tested the hypothesis that cancer cells may sense serum
deprivation and up-regulate transcription of those factors
required for adaptation to hypoxia. The FVII-gene acti-
vation under real hypoxia in the presence of serum is
rather moderate compared with that induced by CoCl2
exposure; however, this may be due to the relatively
weak expression levels of endogenous HIFs (9). It is also
possible that side effects of CoCl2 exposure including gen-
eration of reactive oxygen species and DNA damage (40)
transmit signals to enhance Sp1–HIF2a-dependent tran-
scription. We found that activation of the FVII gene is
synergistically enhanced in a deacetylation-dependent
manner under the serum-free conditions, in which
ER stress is induced. Given that HIF expression in
OVSAYO cells is dramatically reduced under glucose-free
conditions and weak under glucose-deprived conditions, it
is plausible that the synergistic activation does not occur
by glucose deprivation as opposed to serum starvation.
Therefore, serum starvation-induced stress may provide
an additional environmental cue to which cells adapt.
We suggest that HDAC4 may be a stress-responsive
deacetylase, such as sirtuins (12), when cells are exposed
to hypoxia. We show that UPR is not responsible for this
synergistic activation and further identiﬁcation of the
mechanisms responsible for this synergism is currently
ongoing in our laboratory.
This study presents a novel transcriptional activation
that is mediated by the interplay between HIF2a/Sp1/
HDAC4, enabling us to understand one of the mechan-
isms of thrombosis in CCC patients. Further exploration
of the genes and cancer phenotypes regulated by this
HRE-independent mechanism will provide a greater
understanding of cellular adaptation that manifests in
response to environmental stresses, and may potentially
lead to the development of new therapeutics for cancers
targeting class IIa HDACs.
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